Recent studies unveiled that the elevation of cell cycle regulators (such as CDK7, CDK6, and CCNE1), and activation of the interferon (IFN) pathway were critical for developing CDK4/6i resistance in breast cancer (8, 9, 10, 11). Here, CDK4 is linked to breast carcinoma.